Search

Author/Creator Yang, Yefa

1. Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial. (June 2020)

Authors:
Li, Jun; Xing, Jingliang; Yang, Yefa; Liu, Jingfeng; Wang, Wentao; Xia, Yong; Yan, Zhenlin; Wang, Kui; Wu, Dong; Wu, Lu; Wan, Xuying; Yang, Tian; Gao, Chunfang; Si, Anfeng; Wang, Hongyang; Wu, Mengchao; Lau, Wan Yee; Chen, Zhinan; Shen, Feng
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 5:Number 6(2020)
Page Start:
548
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization‐treated hepatocellular carcinoma patients. Issue 7 (18th June 2014)

Authors:
Yuan, Peng; Wang, Shen; Zhou, Feng; Wan, Shaogui; Yang, Yefa; Huang, Xiaojun; Zhang, Zhaohui; Zhu, Yong; Zhang, Hongxin; Xing, Jinliang
Journal:
Cancer science
Issue:
Volume 105:Issue 7(2014:Jul.)
Page Start:
825
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗